Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Industry News

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

July 21, 2021

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

October 10, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Industry News

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

October 22, 2015

News Industry News

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

October 13, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

October 31, 2013

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Industry News

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

November 09, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

August 28, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

Advertisement

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

Doctor's Best Introduces Two New Heart Health Supplements

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

Abbott to Present New Data for Key Vascular Products at TCT 2011

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content